GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabist Company Holdings Inc (OTCPK:CBSTF) » Definitions » Net Income

CBSTF (Cannabist Company Holdings) Net Income : $-124.1 Mil (TTM As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cannabist Company Holdings Net Income?

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Cannabist Company Holdings's Net Income for the three months ended in Sep. 2024 was $-1.9 Mil. Its Net Income for the trailing twelve months (TTM) ended in Sep. 2024 was $-124.1 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. Cannabist Company Holdings's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was $-0.00.


Cannabist Company Holdings Net Income Historical Data

The historical data trend for Cannabist Company Holdings's Net Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabist Company Holdings Net Income Chart

Cannabist Company Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income
Get a 7-Day Free Trial -96.27 -95.79 -143.10 -416.01 -175.71

Cannabist Company Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -36.73 -72.78 -35.07 -14.34 -1.86

Cannabist Company Holdings Net Income Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= EBITDA - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

Cannabist Company Holdings's Net Income for the fiscal year that ended in Dec. 2023 is calculated as

Net Income(A: Dec. 2023 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=-168.898+-5.389+0+-1.425
=-175.7

Cannabist Company Holdings's Net Income for the quarter that ended in Sep. 2024 is calculated as

Net Income(Q: Sep. 2024 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=20.075+-21.838+0+-0.096999999999998
=-1.9

Net Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-124.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabist Company Holdings  (OTCPK:CBSTF) Net Income Explanation

Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

Cannabist Company Holdings's Earnings per Share (Diluted) (EPS) for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Cannabist Company Holdings Net Income Related Terms

Thank you for viewing the detailed overview of Cannabist Company Holdings's Net Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabist Company Holdings Business Description

Traded in Other Exchanges
Address
680 Fifth Avenue, 24th Floor, New York, NY, USA, 10019
Cannabist Company Holdings Inc is a cultivator, manufacturer, and provider of medical cannabis products and services. Some of its products are Vaporization Oil, Sublingual Tinctures, Lotions, Hard Pressed Tablets, and Suppositories, among others. The company markets its products under ClaraCeed, Seed & Starin, and Triple 777 brands among others.
Executives
David Sirolly officer: Chief Legal Officer/GC C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Julie A Hill director WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Jeff Clarke director COMPUTER ASSOCIATES INTERNATIONAL INC, ONE COMPUTER ASSOCIATES PLAZA, ISLANDA NY 11746
Derek Watson officer: Chief Financial Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
David James Hart officer: Chief Operating Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Alison Worthington director C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Bryan Olson officer: Chief People/Admin Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Nicholas Vita director, officer: Chief Executive Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Rosemary Mazanet officer: Chief Scientific Officer 175 TOYOTA PLAZA, 7TH FLOOR, MEMPHIS TN 38103
Guy Hussussian officer: Chief Data Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Jesse Channon officer: Chief Growth Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Michael Abbott director, officer: Chairman C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Philip Goldberg director C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Frank Savage director
Kennedy James A C director T ROWE PRICE GROUP INC, 100 E PRATT ST, BALTIMORE MD 21202

Cannabist Company Holdings Headlines

From GuruFocus

Q4 2021 Columbia Care Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024

Columbia Care Inc Business Update Call Transcript

By GuruFocus Research 02-13-2024

Q1 2022 Columbia Care Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024

Columbia Care Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Q2 2023 Columbia Care Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024

Columbia Care Inc. - Special Call Transcript

By GuruFocus Research 02-13-2024

Q1 2021 Columbia Care Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024